The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 25, 2014

Filed:

Apr. 28, 2005
Applicants:

Juan Manuel Irache Garreta, Pamplona, ES;

Carlos Gamazo DE LA Rasilla, Obanos, ES;

Maria Luisa Sanz Larruga, Pamplona, ES;

Marta Ferrer Puga, Pamplona, ES;

Beatriz San Román Aberasturi, Alsasua, ES;

Hesham H. A. Salman, Pamplona, ES;

Sara Gómez Martinez, Logrono, ES;

Javier Ochoa Rep{dot Over (A)}raz, Olaz de Egüés, ES;

Inventors:

Juan Manuel Irache Garreta, Pamplona, ES;

Carlos Gamazo De La Rasilla, Obanos, ES;

Maria Luisa Sanz Larruga, Pamplona, ES;

Marta Ferrer Puga, Pamplona, ES;

Beatriz San Román Aberasturi, Alsasua, ES;

Hesham H. A. Salman, Pamplona, ES;

Sara Gómez Martinez, Logrono, ES;

Javier Ochoa Rep{dot over (a)}raz, Olaz de Egüés, ES;

Assignee:

Universidad de Navarra, Pamplona (Navarra), ES;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 36/00 (2006.01); A61K 36/06 (2006.01); A61K 39/112 (2006.01); A61K 39/39 (2006.01); B82Y 5/00 (2011.01); A61K 51/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 36/00 (2013.01); A61K 9/14 (2013.01); A61K 51/1244 (2013.01); A61K 2201/103 (2013.01); A61K 36/06 (2013.01); A61K 39/0275 (2013.01); A61K 39/39 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/55594 (2013.01); B82Y 5/00 (2013.01); Y10S 977/773 (2013.01);
Abstract

The composition for stimulating an immune response in a subject comprises methyl vinyl ether and maleic anhydride copolymer-based nanoparticles. Said nanoparticles may further contain an allergen or an antigen and/or an immunostimulating agent, which may be contained inside said nanoparticles and/or at least partially coating the surface of said nanoparticles, and optionally a cross-linking agent. The immune response stimulating composition is useful as an adjuvant in immunotherapy and vaccines.


Find Patent Forward Citations

Loading…